Skip to main content
Premium Trial:

Request an Annual Quote

Genomic Solutions Erroneously Refiles 2000 IPO Forms: May 23, 2005

This article has been updated and corrected from an initial version, which cited a Reuters report that Genomic Solutions had filed for an IPO today.

 

NEW YORK, May 23 (GenomeWeb News) - Genomic Solutions, a subsidiary of Harvard Bioscience, erroneously refiled its initial public offering documents from 2000 earlier today.

 

The registration forms were later removed from the SEC's web site, but not before several wire services reported that the company was filing for an IPO of up to $100 million in common stock.

 

A Genomic Solutions spokesman told Dow Jones earlier today that the forms it released were an "erroneous reissue."

 

Neither Genomic Solutions nor Harvard Bioscience returned GenomeWeb News' calls for comment.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.